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Cell models provide important tools to investigate the mechanisms modulating the insulin-signaling cascade. Insulin interaction and
subsequent signaling of cells is complex and regulated at multiple levels: receptor abundance, binding dynamics, phosphorylation/
dephosphorylation of tyrosine and serine/threonine residues, and subsequent interactions of key intracellular messengers. We report early
insulin signaling events in the mouse Sol8 myogenic cell line. Sol8 cells responded to insulin by increasing total IRS-1, p85 PI3-kinase and
tyrosine phosphorylated IRS-1 (pY-IRS-1) at 10 min (Pb0.05), but not at 1 min of insulin stimulation. The dose–response relationships at 10-
min insulin (10 to 300 nM) stimulation showed that IRS-1 and pY-IRS-1 responded to 100 and 300 nM insulin, and the p85 PI3-kinase
response peaked at 30 nM insulin. PI3-kinase appeared to be present in high abundance and, in response to insulin, recruitment to the insulin
receptor tyrosine kinase (IR) of IRS-1 and PI3-kinase was observed. The increase in IRS-1 detected in IR immunoprecipitates was twofold,
while the corresponding increase in PI3-kinase was threefold, suggesting direct recruitment of PI3-kinase to the IR. PI3-kinase detected in
IRS-1 immunoprecipitates in response to insulin increased 1.7-fold. An ultimate target of this pathway, GLUT4 recruitment to the PM, was
delayed (30 min), the increase in GLUT4 being of similar magnitude (1.6-fold) to the early signaling events. Saturation binding analysis
indicated that IR in the plasma membrane was not down-regulated in response to insulin. The present study suggests that early signaling
events in the insulin cascade are invoked in Sol8 myogenic cells and that this cell line provides a useful model to study insulin signaling.
D 2004 Elsevier B.V. All rights reserved.Keywords: Signal transduction; Insulin; Insulin receptor; IR; IRS-1; PI3-kinase; Sol8; Muscle1. Introduction
Skeletal muscle is the major metabolic tissue of the
body. Muscle functions to allow limb movement, but it
also provides a readily available source of metabolites for
use by other tissues such as bone and brain. As insulin
operates to facilitate normal muscle metabolism, muscle is
an important tissue in the study of insulin signaling, for
which there are many models available. For example,0167-4889/$ - see front matter D 2004 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbamcr.2004.08.005
Abbreviations: IR, insulin receptor kinase; IRS-1, insulin receptor
substrate-1; PI, phosphatidylinositol
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E-mail address: rodhill@uidaho.edu (R.A. Hill).cultured myogenic cells isolated from human subjects
with high or low insulin sensitivity [1], immortalized cell
lines such as the mouse C2C12 [2], BC3H-1 [3], or the
rat L6 [4, 5], have been used as skeletal muscle models,
each with its own strengths and weaknesses. The Sol8
myogenic cell line is derived from oxidative (soleus)
muscle [6]. Sol8 cells are characterized by having large
numbers of mitochondria, which allows these cells to
readily oxidize fatty acids as an energy source although
the pathways of action are not yet well described [7].
Modulation of energy flux in Sol8 cells is regulated, in
part, by insulin, and the potential to utilize fatty acids
rather than glucose for energy suggests that Sol8 may
exhibit insulin resistance. To date, only limited aspects ofta 1693 (2004) 205–211
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cell model [8].
In the insulin-signaling cascade, the potential for
variation in downstream signal recruitment via IRS is
substantial. IRS proteins associate with the IR NPEY motif
via a phosphotyrosine-binding domain (PTB) together with
ancillary membrane phosphoinositide binding via the IRS
pleckstrin homology (PH) domain. IRS-1 also possesses at
least eight C-terminal tyrosine phosphorylation sites,
together with a potential counter-regulatory serine-307
phosphorylation site adjacent to the PTB domain [9–14].
Direct binding of PI3-kinase to the IR has been demon-
strated in both muscle and liver [15–22] and this mechanism
has been proposed to have counter-regulatory effects on
insulin signaling in gestational diabetes [20]. The objective
of the present study was to characterize early insulin
signaling events in Sol8 cells, and explore possible
inhibition of signaling.2. Methods
2.1. Myogenic cells and cell culture
Sol8 myogenic cells were cultured in DMEM with
10% FCS plus penicillin/streptomycin (CM) in a humidi-
fied environment at 37 8C and 5% CO2 enriched air.
Cultures were expanded and allowed to grow to 80–90%
confluence in an undifferentiated state. For insulin treat-
ments, cultures were grown to subconfluence in CM,
washed in DMEM (3) and the insulin treatments applied
in DMEM plus 0.3 mM BSA, fatty acid-free (Sigma
Chemical, St Louis, MO).
2.2. Preparation of cell lysates
Following experimental treatments, cultures were
washed (3) in DMEM, and 15 ml of lysis buffer, 50
mM Tris, 1% NP-40, 0.25% sodium deoxycholate, 150 mM
NaCl, 1 mM EDTA, 1 mM sodium vanadate, plus
dComplete mini-cocktail (Roche Diagnostics, GmBH, Ger-
many) pH 7.3, was added. Culture flasks were then
immersed in liquid nitrogen for 30 s to ensure complete
cell lysis. Cell lysates were then incubated at 4 8C for 2 h,
then aliquoted and stored at 80 8C. Total protein was
determined using the BCA assay (Pierce Chemical, Rock-
ford, IL) and DNAwas extracted from an aliquot to quantify
cell number.
2.3. Immunoprecipitation
For each specific insulin cascade protein studied, 5 Al of
specific antibody was preincubated with 20-Al Protein-A
Sepharose (Pierce) for 2 h at 4 8C, and 1 ml of cell lysate
was then added and incubated with constant agitation
overnight at 4 8C. The mixture was then centrifuged at14000g for 2 min, the supernatant aspirated and the pellet
resuspended in 1-ml lysis buffer. The beads were washed a
further two times and finally suspended in 50-Al non-
reducing Laemmli buffer. The specific immunoprecipitating
antibodies (Upstate Biotechnology, Lake Placid, NY) were
each raised in rabbits and were directed against either the IR
h-chain, IRS-1 or PI3-kinase (p85).
2.4. Electrophoresis and immunodetection
Proteins in immunoprecipitates were resolved using
SDS-PAGE under non-reducing conditions (Hoefer Scien-
tific Instruments, San Francisco, CA), transferred to
nitrocellulose (Semi-dry Transfer, Hoefer, Model TE-70),
and the proteins detected using a rabbit antibody as shown
for immunoprecipitation as primary antibody (1:1000), and
mouse monoclonal (clone 4G10) anti-phosphotyrosine
(Upstate Biotechnology) (1:1000) to detect tyrosine
phosphorylated proteins. Blots were incubated simultane-
ously with dual secondary antibodies (1:5000): Alexa
Fluor 680-conjugated goat anti-rabbit IgG (Molecular
Probes, Eugene, OR) and IRDye 800-conjugated goat
anti-mouse IgG (Rockland, Gilbertsville, PA). Total
specific proteins and phosphorylated proteins were simul-
taneously detected using an dOdysseyT dual infrared laser
fluorescence imager (Li-Cor Biosciences, Lincoln, NE)
with resolution set to 169 Am.
2.5. Plasma membrane preparation and GLUT4 analysis
Following insulin treatments, plasma membranes were
prepared through a sucrose cushion as described [23], and
100-Al aliquots stored at 80 8C. Protein content was
determined using the BCA assay with bovine serum
albumin as the standard (Pierce). GLUT4 was immuno-
precipitated using an anti-GLUT4 antibody (Abcam,
Cambridge, UK), electrophoresed, blotted under reducing
conditions and detected as described above.
2.6. Saturation binding analysis
Insulin binding to IR was quantified on whole cells using
saturation binding analysis. Bovine insulin was iodinated by
the method of Salacinski et al. [24]. Cells were grown to 80–
90% confluence, and not treated or treated with insulin (100
nM). Cells were then washed (3) with DMEM and
incubated for 2 h at room temperature in the presence of
six concentrations (in triplicate) of 125I-insulin alone (con-
centration range 30 to 2000 pM) to determine total binding,
or with the addition of 500 nM insulin to define nonspecific
binding, in 250 Al of a buffer containing 100 mM HEPES,
120 mM NaCl, 5 mM KCl, 1.2 mM MgSO4, 1 mM EDTA,
10 mM d-glucose, 15 mM sodium acetate, 0.1% BSA, plus
protease inhibitor cocktail (Roche Diagnostics) pH 7.6 [25,
26]. Bound and free ligands were separated by centrifugation
and resuspension of cells (2) at 3000g for 20 min. Bound
Fig. 2. Dose–response effects of insulin on IRS-1 and p85 PI3-kinase in
Sol8 cultures. Cells were stimulated with insulin for 10 min at the indicated
concentrations, lysed and IRS-1 or PI3-kinase immunoprecipitated using an
excess of specific antibody bound to Protein-A agarose. Immunoprecipi-
tates were electrophoresed, Western-blotted using the same antibody for
total specific proteins or anti-phosphotyrosine for pY-IRS-1, and proteins
quantified using the Odyssey dual infrared laser fluorescence system. Data
were expressed as percent of the control value for each protein form
(zPb0.1, *Pb0.05, **Pb0.01, vs. 0 insulin, n=5–6).
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ard, Meridan, CT). Data were modeled using the Ligand
Binding Module in SigmaPlot version 8 (SPSS, Chicago,
IL), and IR affinity and receptor number determined.
2.7. Experimental treatments and design
In Experiment 1, a time-course response to insulin was
determined. Cell cultures were prepared in 150-cm2 flasks
and incubated in the presence of bovine insulin (Gibco
InVitrogen, Carlsbad, CA), 100 nM for either 0, 1, 10 or 30
min. Cells were also maintained in CM and processed
together with insulin-treated cells as outlined above. In
Experiment 2, dose–response to insulin was determined.
Cells were incubated for 10 min with the following
concentrations of insulin (nM): 0, 10, 30, 100, and 300, or
in CM, and pathway activation determined as for experi-
ment 1. For each experiment, control vs. treatments were
resolved and blotted from the same gel and each of these
was replicated three to six times. Only within blot data are
reported (paired t test).3. Results
3.1. Insulin response of IRS-1 and p85 PI3-kinase
In both experiments 1 (time course) and 2 (dose–
response), total IRS-1 and PI3-kinase were responsive to*
**
**
Fig. 1. Effect of insulin (100 nM) on total IRS-1 (n, left axis), tyrosine
phosphorylated IRS-1 (pY-IRS-1; z, right axis) and p85 PI3-kinase (x, left
axis) in Sol8. (Note different scales.) Cells were stimulated with insulin for
the indicated times, lysed and IRS-1 or p85 PI3-kinase immunoprecipitated
using an excess of specific antibody bound to Protein-A agarose.
Immunoprecipitates were electrophoresed, Western-blotted using the same
antibody for total specific proteins or anti-phosphotyrosine for pY-IRS-1,
and proteins quantified using the Odyssey dual infrared laser fluorescence
system (zPb0.1, *Pb0.05, **Pb0.01, vs. 0 insulin, n=3). Representative
blots from each study are shown.insulin (Figs. 1 and 2). In the time-course study, the rise in
both IRS-1 and PI3-kinase peaked at 10 min (Pb0.05;
b0.01, respectively), PI3-kinase remaining elevated
(Pb0.01), at 30 min of insulin stimulation. In experiment
2, maximal IRS-1 response was detected at 100 and 300
nM insulin, while PI3-kinase appeared responsive only to
30 nM insulin. Total IRS-1 was closely reflected by pY-
IRS-1 in both studies also showing a peak at 10 min in the
time-course study (Pb0.1) and in experiment 2 in response
to 100 and 300 nM insulin (Pb0.1). Although abundance
of total IRS-1 and PI3-kinase is not a direct measure of
insulin signaling, the increase in total messenger indicates
an insulin-specific action on either specific protein syn-
thesis or inhibition of degradation. A direct indicator of
insulin action, tyrosine phosphorylated IRS-1, appeared to
be only weakly responsive to insulin.
3.2. Recruitment of IRS-1 and p85 PI3-kinase to IR
Consistent with the temporal response of total pY-IRS-
1, IRS-1 recruited specifically to IR peaked at 10-min
insulin stimulation (Fig. 3, Pb0.05). The temporal response
of PI3-kinase recruited to IR also peaked after 10-min
insulin (Pb0.05).
3.3. Recruitment of p85 PI3-kinase to IRS-1
In Sol8, recruitment of PI3-kinase to IRS-1 showed a
consistent temporal pattern with the observations reported
above. The response appeared to peak after 10 min of
insulin stimulation (Pb0.01, Fig. 4). Thus, insulin
signaling from IR through IRS-1 and PI3-kinase, the
classical pathway of early insulin cascade signaling, may
 Fig. 3. Effect of insulin (100 nM) on recruitment of IRS-1 (n) and p85 PI3-
kinase (x) to the insulin receptor (IR) in Sol8 cultures. Cells were
stimulated with insulin for the indicated times, lysed and proteins
immunoprecipitated using an excess of anti-IR antibody bound to
Protein-A agarose. Immunoprecipitates were electrophoresed, co-precipi-
tated proteins Western-blotted using either anti-IRS-1 or anti-p85 PI3-
kinase and quantified using the Odyssey dual infrared laser fluorescence
system (*Pb0.05 vs. 0 insulin, n=3). Representative blots from each study
are shown.
Fig. 5. Effect of insulin (100 nM) on recruitment of GLUT4 to the plasma
membrane in Sol8. Cells were stimulated with insulin for the indicated
times and lysed. Plasma membranes were prepared and proteins immuno-
precipitated using an excess of anti-GLUT4 antibody bound to Protein-A
agarose. Immunoprecipitates were electrophoresed, Western blotted using
the same antibody and proteins quantified using the Odyssey dual infrared
laser fluorescence system. (*Pb0.05 vs. 0 insulin, n=3). A representative
blot is shown.
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regulated and apparently recalcitrant to insulin at 30-min
incubation.Fig. 4. Effect of insulin (100 nM) on p85 PI3-kinase recruitment to IRS-1.
Cells were stimulated with insulin for the indicated times, lysed and
proteins immunoprecipitated using an excess of anti-IRS-1 antibody bound
to Protein-A agarose. Immunoprecipitates were electrophoresed, and co-
precipitated p85 PI3-kinase was Western-blotted and quantified using the
Odyssey dual infrared laser fluorescence system (**Pb0.01 vs. 0 insulin,
n=6). A representative blot is shown.3.4. GLUT4 recruitment to the plasma membrane
To examine the effects of insulin on an important target
of the IR–PI3-kinase pathway, plasma membranes were
prepared, and the levels of GLUT4 quantified. Early
variation in plasma membrane GLUT4 was not detected,
but by 30 min following insulin stimulation, GLUT4 was
elevated more than 1.6-fold (Pb0.05, Fig. 5). This
observation is also consistent with the delayed response
expected, following early signaling events at around 10 min
post-insulin stimulation. These data appear to be in agree-
ment with the insulin-sensitive state of Sol8, with GLUT4
recruitment increasing over time, although earlier signaling
events had peaked and returned to basal values.
3.5. Saturation binding analysis of IR
The effect of 10-min insulin (100 nM) stimulation on IR
number (Bmax) and affinity (KD) in Sol8 was examined. The
KD fell within the expected range and was not affected by
insulin treatment (control, 2.6F2.3 nM; insulin treated,
4.8F2.5 nM). In addition, Bmax was apparently unchanged
by insulin treatment (control, 10.9F7.3 pM; insulin treated,
20.0F17.0 pM).4. Discussion
Sol8 myogenic cells provide a useful model for the study
of the complex pathways activated by insulin. Insulin acts
on multiple cellular processes including the regulation of
energy uptake and partitioning, amino acid uptake and
progression to mitosis and differentiation. Although one
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recently reported in the Sol8 model [8], there have been no
reports of early insulin signaling in this model.
Recruitment and activation of IRS-1 and p85 PI3-kinase
occurs in response to insulin although each of these
messengers may be involved in multiple pathways [27].
Thus, these messengers are part of the complex interplay
between signals arising at the cell membrane and of the
regulation of cellular metabolism. Sol8 cells, being derived
from oxidative muscle, have the potential to readily utilize
fatty acids or glucose as energy substrate and thus provide a
model in which switching between the hormone pathways
regulating energy substrate partitioning has the potential to
invoke insulin resistance [28].
Sol8 early insulin signaling appeared to be responsive,
showing tyrosine phosphorylation of IRS-1, recruitment of
IRS-1 to the IR, and p85 PI3-kinase recruitment to IRS-1.
The order of magnitude of each of these events in response
to insulin was similar, increasing 1.5- to 2-fold over basal
levels. However, it appears that PI3-kinase may be present
in great abundance in these cells (Fig. 1), and direct
recruitment of PI3-kinase to the IR may be a mechanism
involved in the fine-tuning of the insulin response.
Recent in vivo or in vitro studies of early events in the
insulin signaling cascade report maximal response times as
2.5 min [29] to 5 min [20,30,31]. Although none of these
studies reported an earlier time-point, an earlier study
reported rapid phosphorylation of the IR and IRS-1 (30 s)
in rat liver, and a slow decrease in IR phosphorylation, with
t1/2=6 min [32]. A study of a similar rat liver model found
variations in levels of IRS-1 and associated PI3-kinase in
plasma membrane, endosomes and cytosol within 30 s and 2
min of insulin stimulation [33], which returned to basal
levels by 15 min post-insulin. In the present study, it appears
that the cells were unresponsive to 1-min insulin stimula-
tion, which may reflect in part a difference between the in
vitro model reported in the present study and these in vivo
studies. The lack of responsiveness of Sol8 at the 30 min
time-point is consistent with the above studies, indicating
that the signaling pathway is down-regulated, and indicating
a normal response to high insulin concentrations rather than
insulin resistance. It should be noted that at the 10-min time-
point, peak response to insulin may have passed. The
precise peak of response appears to vary between models,
but appears to be invoked from as rapidly as 30 s [32] and
be maintained for up to 15 min [33]. Thus, it is possible that
the kinetics of the insulin response in the present study is
similar to those reported in in vivo studies cited above.
However, at 1 min of insulin stimulation, no response in
early insulin signaling was detected.
A mechanism believed to down-regulate insulin signal-
ing—the direct binding of p85 PI3-kinase to the IR [20–
22]—may be invoked in Sol8. Co-precipitation of both IRS-
1 and p85 with the IR may occur via a number of possible
mechanisms. p85 may be bound to pY-IRS-1 associated
with pY-IR and direct binding of p85 to pY-IR is possible.The high affinity binding site, pYMxM, recognized by the
SH2 domains of p85, occurs at five sites on murine IRS-1
[34]. Furthermore, the activated mouse IR (and the type 1
IGF receptor) do not possess such a high affinity site but
have a lower affinity, C-terminal binding site, pYTHM,
which is also recognized by p85 SH2 domains. It appears
that the high abundance of p85 PI3-kinase in Sol8, even in
those not stimulated with insulin, may be a factor in
modulation of insulin signaling. Although it is difficult to
precisely quantify the insulin cascade proteins using the
methods utilized here, it does appear that an excess
abundance of PI3-kinase over IRS-1 may contribute to the
mechanism of fine-tuning the intracellular response to
insulin. The relative affinity of pYMxM on IRS-1 versus
that of the pYTHM site on the IR may affect the distribution
of PI3-kinase between the IR and IRS-1. The distribution
would also be affected by the relative concentrations of each
of these messengers adjacent to the plasma membrane.
Differences in these affinities and basal concentrations of
each messenger may explain subtle differences in recruit-
ment patterns in similar sub-plasma membrane compart-
ments. At the peak time-point (10 min) in response to
insulin, PI3-kinase recruitment to the IR represented a
threefold increase from basal, which had returned to basal
level by 30-min insulin stimulation. The corresponding
increase in IRS-1 recruitment to the IR represented a
twofold increase. It appears that although these cells are
responsive to insulin, direct recruitment of PI3-kinase to the
IR may provide a mechanism to modulate signaling.
Quenching of the response to this hyperphysiological
concentration of insulin was clearly invoked by 30-min
insulin stimulation.
Recruitment of IRS-1 in the present study shows some
subtle differences from other models. In an in vivo study in
mouse gastrocnemius muscle, Shao et al. [20] demonstrated
an approximately fivefold increase in pY-IRS-1 in normal
versus a threefold increase in gestational diabetes. In
comparison, pY-IRS-1 peaked at approximately 1.5-fold
basal in the present study on a background of increasing
total IRS-1. In contrast, there was apparently no change in
total IRS-1 in either group in the previous study [20] in
response to insulin. Further investigation is required to
clarify the importance of these apparent differences.
GLUT4 recruitment to the plasma membrane (PM) is
delayed following early insulin-signaling cascade events,
the response observed in the present study being consistent
with other insulin-sensitive models. An in vivo study in
normal and GLUT4 transgenic mice [35] showed in normal
mice, in response to a maximal dose of insulin, that GLUT4
recruitment to the PM increased by approximately 2.5-fold.
In a later report [36], these workers noted the possibility that
an activation process may be required to describe functional
glucose transporters accurately; a view supported by others
[37]. Other in vivo studies of GLUT4 response in insulin-
sensitive models indicate that a two- to fivefold increase in
PM GLUT4 in response to insulin may be expected [38–41].
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Sol8 is consistent with normal insulin sensitivity.
A number of studies have reported that down-regulation
of IR following insulin stimulation requires several hours
[42–44]. Thus, little change in receptor number would be
expected during the 1- to 30-min insulin stimulation period
used in the present study. Furthermore, the KD values are in
close agreement with others [43]. We have not found other
estimates of receptor number in myogenic cells in the
literature. The values reported here (range 11 to 20 pM,
equivalent to 3 to 6 fmol per 106 cells), is somewhat in
excess of values reported for small, chromafin cells, 0.25
fmol per 106 cells [43,45].
In conclusion, early insulin-cascade signaling in Sol8
myogenic cells is responsive to insulin. These cells, being
derived from an oxidative muscle (soleus), provide a useful
model for exploring partitioning of energy substrate
utilization processes, through which early insulin signaling
events interact with other regulatory axes.Acknowledgments
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